Rights and Permissions
Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, David R Boulware, Todd C Lee, Rachel Hess, Alexander J Lankowski, Emily G McDonald, J Philip Miller, William G Powderly, Matthew F Pullen, Jeffrey T Rado, Michael W Rich, Joshua T Schiffer, Julie Schweiger, Adam M Spivak, Angela Stevens, Simone N Vigod, Payal Agarwal, Lei Yang, Michael Yingling, Torie R Gettinger, Charles F Zorumski, Eric J Lenze, The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial, Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad419, https://doi.org/10.1093/ofid/ofad419. https://academic.oup.com/ofid/article/10/8/ofad419/7238414?login=true. © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Reiersen, Angela M; Mattar, Caline; Miller, J Philip; Powderly, William G; Rich, Michael W; Schweiger, Julie; Stevens, Angela; Yang, Lei; Yingling, Michael; Gettinger, Torie R; Zorumski, Charles F; Lenze, Eric J; and et al., "The STOP COVID 2 study: Fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully remote randomized controlled trial." Open Forum Infectious Diseases. 10, 8. ofad419 (2023).